BeyondSpring (BYSI) IV bid into data

November 11, 2021 4:26 AM EST

BeyondSpring (NASDAQ: BYSI) 30-day option implied volatility is at 271; compared to its 52-week range of 73 to 293 into the FDA has a Prescription Drug User Fee Act target action date set for the plinabulin NDA of November 30. Call put ratio 1 call to 1 put.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Options

Related Entities

Options, PDUFA, FDA